Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Vanda Pharmaceuticals Inc patents

Recent patent applications related to Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Vanda Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Vanda Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "V" | Vanda Pharmaceuticals Inc-related inventors




Date Vanda Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
08/24/17Method of treatment
07/06/17Highly purifid pharmaceutical grade tasimelteon
06/22/17Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
06/15/17Treatment of schizophrenia
06/15/17Method of treatment
05/11/17Benzisoxazoles
04/13/17Treatment of circadian rhythm disorders
03/30/17Treatment of circadian rhythm disorders
03/30/17Method of treatment
12/15/16Method and composition for treating a serotonin receptor-mediated condition
12/08/16Melatonin agonist treatment
09/15/16Antipsychotic treatment based on snp genotype
08/04/16Treating neurodegenerative disease with fenofibrate and analogs thereof
08/04/16Treating neurodegenerative disease with fenofibrate and analogs thereof
07/28/16Treatment of cyr61- and vegf-mediated conditions
07/14/16Cancer treatment
07/14/16Multiple myeloma treatment
06/16/16Antipsychotic treatment based on drd2 or ankk1 snp genotype
03/03/16Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
02/25/16Methods for the administration of iloperidone
12/24/15Method of treatment based on polymorphisms of the kcnq1 gene
11/05/15Antipsychotic treatment based on drd2 or ankk1 snp genotype
09/17/15Method of predicting a predisposition to qt prolongation
09/17/15Methods for the administration of iloperidone
08/13/15Method of predicting a predisposition to qt prolongation
08/13/15Method of predicting a predisposition to qt prolongation
08/13/15Method of predicting a predisposition to qt prolongation
08/06/15Treatment of circadian rhythm disorders
07/16/15Method of treatment
06/18/15Method of treatment based on polymorphisms of the kcnq1 gene
05/28/15Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
03/19/15Melatonin agonist treatment
02/12/15Iloperidone metabolite for use in the treatment of psychiatric disorders
01/22/15Treatment of circadian rhythm disorders
07/10/14Method and composition for treating an alpha adrenoceptor-mediated condition
05/08/14Methods for the administration of iloperidone
05/08/14Method of administration and treatment
03/20/14Method and composition for treating a serotonin receptor-mediated condition
02/13/14Methods for the administration of iloperidone
02/06/14Methods for the administration of iloperidone
08/01/13Treatment of circadian rhythm disorders
05/31/12Use of a melatonin agonist for the treatment of sleep disorders including primary insomnia
03/08/12Method of predicting a predisposition to qt prolongation
03/08/12Method of predicting a predisposition to qt prolongation
03/01/12Antipsychotic treatment based on drd2 or ankk1 snp genotype
02/09/12Method of predicting a predisposition to qt prolongation
02/02/12Method of treatment based on polymorphisms of the kcnq1 gene







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Vanda Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vanda Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';